Drugs / multivalent pneumococcal conjugate formulation 1
last change Mar 2019 re-read 2 minutes ago

multivalent pneumococcal conjugate formulation 1

Developed for
pneumococcal infection
Investigated by
Pfizer

Trials 1 · a red edge is where a trial was stopped

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03642847 Aug 2018 → Mar 2019 pneumococcal infection Pfizer Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as multivalent pneumococcal conjugate formulation 1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03642847